Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome

Fu, Y; Zhang, XY; Qin, SB; Nie, XY; Shi, LW; Shao, H; Liu, H

Nie, XY (corresponding author), Peking Univ, Sch Pharmaceut Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China.

PHARMACOGENOMICS, 2020; 21 (1): 33

Abstract

Aim: This study aimed to evaluate the cost-effectiveness of CYP2C19 loss-of-function(LOF) allele-guided antiplatelet therapy compared with the univers......

Full Text Link